Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain

Neurobiology of Aging

Volumn 24, Issue 7, 2003, Pages 921-926

  Licastro, Federico ^a   Grimaldi, Luigi Maria Edoardo ^b   Bonafè, Massimiliano ^a   Martina, Chiappelli ^a   Olivieri, Fabiola ^c   Cavallone, Luca ^c   Giovanietti, Simona ^c   Masliah, Eliezer ^d   Franceschi, Claudio ^a,c  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b Department of Neuroscience ^*  (Italy)

^c INRCA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alzheimer's disease risk; Blood and brain IL 6 levels; IL 6 gene

Indexed keywords

CYTOKINE; INTERLEUKIN 6;

AGED; ALLELISM; ALZHEIMER DISEASE; ARTICLE; BLOOD; BRAIN; CONTROLLED STUDY; DEMENTIA; FEMALE; GENE; GENETIC POLYMORPHISM; GENOTYPE; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; RISK FACTOR;

EID: 0043092123     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(03)00013-7     Document Type: Article

References (36)

1. Angelis P., Scharf S., Mander A., Vajda F., Christophidis N. Serum interleukin-6 and interleukin-6 soluble receptor in Alzheimer's disease. Neurosci. Lett. 244:1998;106-108.
2. Bagli M., Papassotiropoulos A., Knapp M., Jessen F., Rao M.L., Maier W.et al. Neurosci. Lett. 283:2000;109-112.
3. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I.et al. Interleukin-6 and α-2-macroglobulin indicate an acute phase state in Alzheimer's disease cortex. FEBS Lett. 285:1991;111-114.
4. Beach T.G., Walker R., McGeer E.G. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia. 2:1989;420-436.
5. Bhojack T.J., DeKosky S.T., Ganguli M., Kamboh M.I. Genetic polymorphisms in the cathepsin D and interleukin-6 genes and the risk of Alzheimer's disease. Neurosci. Lett. 288:2000;21-24.
6. Bowcock A.M., Ray A., Erlich H., Seghal P.B. Rapid detection and sequencing of alleles in the 3′ flanking region of the interleukin-6 gene. Nucleic Acid Res. 17:1989;6855-6864.
7. Breitner J.C.S., Gau B.A., Welsh K.A., Plassman B.L., McDonald W.M., Helms M.J.et al. Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology. 44:1994;227-232.
8. Campbell I.L., Abraham C.R., Masliah E., Kemper P., Inglis J.D., Oldstone M.B.et al. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc. Natl. Acad. Sci. USA. 90:1993;10061-10065.
9. Corder E.H., Saunders A.M., Strittmatter W.J., Schmechel D.E., Gaskell P.C., Small G.W.et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
10. Ershler W.B. Interleukin-6: a cytokine for gerontologist. J. Am. Geriatr. Soc. 41:1993;176-181.
11. Fagiolo U., Cossarizza A., Scala E., Fanales-Belasio E., Ortolani C., Cozzi E.et al. Increased cytokine production in mononuclear cells of healthy elderly people. Eur. J. Immunol. 23:1993;2375-2378.
12. Fishman D., Faulds G., Jeffery R., Mohamed-Ali V., Yudkin J.S., Humphries S.et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J. Clin. Invest. 102:1998;1369-1376.
13. Grimaldi L.M.E., Casadei V.M., Ferri C., Veglia F., Licastro F., Annoni G.et al. Association of early-onset Alzheimer's disease with an interleukin-1α gene polymorphism. Ann. Neurol. 47:2000;361-365.
14. Gruol D.L., Nelson T.E. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol. Neurobiol. 15:1997;307-339.
15. Huell M., Strauss S., Volk B., Berger M., Bauer J. Interleukin-6 is present in early stages of plaque formation and is restricted to the brain of Alzheimer's disease patients. Acta Neuropathol. 89:1995;544-551.
16. Kalman J., Juhasz A., Laird G., Dickens P., Jardanhazy T., Rimanoczy A.et al. Serum interleukin-6 levels correlate with the severity of dementia in Down syndrome and in Alzheimer's disease. Acta Neurol. Scand. 96:1997;236-240.
17. Lanzrein A.S., Johnston C.M., Perry V.H., Jobst K.A., King E.M., Smith A.D. Longitudinal study of inflammatory factors in serum, cerebrospinal fluid, and brain tissue in Alzheimer disease: interleukin-1beta, interleukin-6, interleukin-1 receptor antagonist, tumor necrosis factor-alpha, the soluble tumor necrosis factor receptors I and II, and alpha1-antichymotrypsin. Alzheimer Dis. Assoc. Disord. 12:1998;215-227.
18. Licastro F., Mallory M., Hansen L.A., Malsiah E. Increased levels of α-1-antichymotrypsin in brains of patients with Alzheimer's disease correlate with activated astrocytes and are affected by APOE 4 genotype. J. Neuroimmunol. 88:1998;105-110.
19. Licastro F., Pedrini S., Caputo L., Annoni G., Davis L.J., Ferri C.et al. Increased plasma levels of interleukin-1, interleukin-6 and α-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain? J. Neuroimmunol. 103:2000;97-102.
20. Licastro F., Pedrini S., Ferri C., Casadei V., Govoni M., Pession A.et al. Gene polymorphism affecting α-1-antichymotrypsin and interleukin-1 plasma levels increases Alzheimer's disease risk. Ann. Neurol. 48:2000;388-391.
21. Licastro F., Pedrini S., Govoni M., Pession A., Ferri C., Annoni G.et al. Apolipoprotein E and α-1-antichymotrypsin allele polymorphism in sporadic and familial Alzheimer's disease. Neurosci. Lett. 270:1999;129-132.
22. Linker-Israeli M., Wallace D.J., Prehn J., Michael D., Honda M., Taylor K.D.et al. Association of IL-6 gene alleles with systemic lupus erythematosus (SLE) and with elevated IL-6 expression. Genes Immunity. 1:1999;45-52.
23. Long J.C., Williams R.C., Urbanek M. An E-M algoritm and testing strategy for multiple locus haplotypes. Am. J. Hum. Genet. 56:1995;799-810.
24. Luterman J.D., Harountunien V., Yemul S., Ho L., Purihit D., Aisen P.S.et al. Cytokine gene expression as a funtion of clinical progression of Alzheimer disease dementia. Arch. Neurol. 57:2000;1153-1160.
25. Mackhann G., Drachman D., Folstein M., Katzman R., Proce D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease. Neurology. 34:1984;939-944.
26. Maes M., DeVos N., Wauters A., Demedts P., Maurits V.W., Neels H.et al. Inflammatory markers in younger versus elderly normal volunteers and in patients with Alzheimer's disease. J. Psychiatr. Res. 33:1999;397-405.
27. McGeer E.G., McGeer P.L. The importance of inflammatory mechanisms in Alzheimer's disease. Exp. Gerontol. 33:1998;371-378.
28. McGeer P.L., Schulzer M., McGeer E.G. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiological studies. Neurology. 47:1996;425-432.
29. Mrak R.E., Sheng J.G., Griffin S.T. Glial cytokines in Alzheimer's disease: review and pathogenetic implications. Hum. Pathol. 26:1995;816-823.
30. Papassitoroupoulos A., Bagli M., Jessen F., Bayer T.A., Maier W., Rao M.L.et al. A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann. Neurol. 45:1999;666-668.
31. Poirier J., Davignon J., Bouthillier D., Kogan S., Bertrand P., Gauthier S. Apolipoprotein E polymorphism and Alzheimer's disease. Lancet. 342:1993;697-699.
32. Rubinsztein D.C. The genetics of Alzheimer's disease. Prog. Neurobiol. 52:1997;447-454.
33. Strauss S., Bauer J., Ganter U., Jonas U., Berger M., Volk B. Detection of interleukin-6 and α-2-macroglobulin immunoreactivity in cortex and hyppocampus of Alzheimer's disease patients. Lab. Invest. 66:1992;223-230.
34. Tehranion R., Hasanvan H., Iverfeldt K., Post C., Shultzberg M. Early induction of interleukin-6 mRNA in the ippocampus and cortex of APPsw transgenic mice Tg2576. Neurosci. lett. 301:2001;54-58.
35. Thorns V., Walter G.F., Licastro F. Effects of IL-6 and IL-1β on aFGF expression and exocitotoxicity in NT2N cells. J. Neuroimmunol. 127:2002;22-29.
36. Yamada K., Kono K., Umegaki H., Yamada K., Iguchi A., Fukatsu T.et al. Decreased interleukin-6 level in the cerebrospinal fluid of patients with Alzheimer-type dementia. Neurosci. Lett. 186:1995;219-221.